Fading Causes with Mukesh Kapila - How Can We Do More Good Than Harm? with Stephen Cornish

Share:

Impact Newswire

News


EPISODE 16: How Can We Do More Good Than Harm? with Stephen Cornish


The story of MSF is one of radical proximity, not just to the patient, but to the political firestorms that create them. As Stephen Cornish, Director of Operations at MSF tells host Mukesh Kapila in this episode, MSF is not merely a medical charity; it is a mirror held up to the "market of misery," forcing the world to look at the victims it would rather ignore. This "arrogance" that Mukesh notes is, in fact, the organization’s primary survival mechanism. By rejecting the "big fat checks" of partisan governments, they have traded financial ease for the moral authority to cross lines that stop others cold. If an organization accepts millions from the same state that is actively a party to a conflict, can it ever truly claim to be an impartial advocate for that state's victims?


This independence necessitates an agonizing moral calculus, leading to the "global triage" that Cornish describes as heart-wrenching. MSF’s history is defined by the tension between the principle of humanity and the reality of being instrumentalized by regimes. Whether they are withdrawing from North Korea because they refuse to be a "fig leaf" for propaganda or staying in Afghanistan to run maternities under the Taliban, the choice is never simple. This prompts a difficult reflection for any observer: is it better for a humanitarian agency to provide a "bad normal" level of care indefinitely, or to strategically withdraw to preserve the capacity for responding to the next catastrophic spike in mortality?


The concept of témoignage, or bearing witness, remains the most controversial and vital weapon in the MSF arsenal. As Cornish notes, while doctors cannot stop conflict, their silence can certainly kill. In the fog of war, where propaganda is an instrument of combat, the simple act of reporting 6,000 poisoning victims in Ghouta becomes a revolutionary act. However, as humanitarian advocacy moves onto platforms like Instagram and into the halls of the UN Security Council, we must ask ourselves where the line falls between life-saving testimony and performative noise. Does a speech at a podium in New York actually change the reality for a patient in a Goma clinic, or does it merely assuage the guilt of the witness?


The "changing humanitarian landscape" suggests a future where the MSF model of 7 million individual donors is no longer just a preference, but a necessity. As traditional UN agencies find themselves "pathetically looking for dollars" and competing for the same public empathy, the distinctiveness of the sans frontières brand faces a new kind of saturation. In a world of increasing walls and closing borders, the true value of MSF may not just be the medicine they provide, but their refusal to accept the world as it is. They remain the indispensable irritant of a global system that often prefers its misery to be quiet, orderly, and well-managed.